Cargando…

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study

Alzheimer’s disease (AD) is an insidious disease. Its distinctive pathology forms over a considerable length of time without symptoms. There is a need to detect this disease, before even subtle changes occur in cognition. Hallmark AD biomarkers, tau and amyloid-β, have shown promising results in CSF...

Descripción completa

Detalles Bibliográficos
Autores principales:	McNicholas, Kym, François, Maxime, Liu, Jian-Wei, Doecke, James D., Hecker, Jane, Faunt, Jeff, Maddison, John, Johns, Sally, Pukala, Tara L., Rush, Robert A., Leifert, Wayne R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685799/ https://www.ncbi.nlm.nih.gov/pubmed/36438010 http://dx.doi.org/10.3389/fnagi.2022.1019296

Ejemplares similares

Salivaomics as a Potential Tool for Predicting Alzheimer’s Disease During the Early Stages of Neurodegeneration
por: François, Maxime, et al.
Publicado: (2021)

Multi-Omics, an Integrated Approach to Identify Novel Blood Biomarkers of Alzheimer’s Disease
por: François, Maxime, et al.
Publicado: (2022)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

NEUBOrg: Artificially Induced Pluripotent Stem Cell-Derived Brain Organoid to Model and Study Genetics of Alzheimer’s Disease Progression
por: Esmail, Sally, et al.
Publicado: (2021)

Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer’s Disease Patients
por: Ju, Ting, et al.
Publicado: (2022)

Age-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease
por: Chua, Jacqueline, et al.
Publicado: (2022)

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer’s Disease and Mild Cognitive Impairment
por: Dong, Ningxin, et al.
Publicado: (2022)

Identifying Alzheimer’s disease and mild cognitive impairment with atlas-based multi-modal metrics
por: Long, Zhuqing, et al.
Publicado: (2023)

Altered local and remote functional connectivity in mild Alzheimer’s disease patients with sleep disturbances
por: Wang, Lei, et al.
Publicado: (2023)

Increased functional connectivity patterns in mild Alzheimer’s disease: A rsfMRI study
por: Penalba-Sánchez, Lucía, et al.
Publicado: (2023)

Effects of Sport Stacking on Neuropsychological, Neurobiological, and Brain Function Performances in Patients With Mild Alzheimer's Disease and Mild Cognitive Impairment: A Randomized Controlled Trial
por: Yang, Ziying, et al.
Publicado: (2022)

Enhancement of Visuospatial Working Memory by the Differential Outcomes Procedure in Mild Cognitive Impairment and Alzheimer’s Disease
por: Vivas, Ana B., et al.
Publicado: (2018)

Identifying Mild Alzheimer's Disease With First 30-Min (11)C-PiB PET Scan
por: Shen, Chushu, et al.
Publicado: (2022)

The effect of physical activity on white matter integrity in aging and prodromal to mild Alzheimer’s disease with vascular comorbidity
por: Konwar, Srijan, et al.
Publicado: (2023)

Loop diuretics association with Alzheimer’s disease risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Specific White Matter Tracts and Diffusion Properties Predict Conversion From Mild Cognitive Impairment to Alzheimer’s Disease
por: Stone, David B., et al.
Publicado: (2021)

Identification of Genetic Networks Reveals Complex Associations and Risk Trajectory Linking Mild Cognitive Impairment to Alzheimer’s Disease
por: Strafella, Claudia, et al.
Publicado: (2022)

Eliciting Implicit Awareness in Alzheimer’s Disease and Mild Cognitive Impairment: A Task-Based Functional MRI Study
por: Tondelli, Manuela, et al.
Publicado: (2022)

Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Chen, Yanru, et al.
Publicado: (2022)

Plasma tau proteins for the diagnosis of mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis
por: Chen, Leian, et al.
Publicado: (2022)

Vision transformers for the prediction of mild cognitive impairment to Alzheimer’s disease progression using mid-sagittal sMRI
por: Hoang, Gia Minh, et al.
Publicado: (2023)

G-quadruplexes and associated proteins in aging and Alzheimer’s disease
por: Vijay Kumar, M. J., et al.
Publicado: (2023)

Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression
por: Yeh, Tsai-Chu, et al.
Publicado: (2022)

Effect of cognitive reserve on amnestic mild cognitive impairment due to Alzheimer’s disease defined by fluorodeoxyglucose-positron emission tomography
por: Kato, Takashi, et al.
Publicado: (2022)

Blood levels of circulating methionine components in Alzheimer’s disease and mild cognitive impairment: A systematic review and meta-analysis
por: Zhao, Yan, et al.
Publicado: (2022)

Olfactory function changes and the predictive performance of the Chinese Smell Identification Test in patients with mild cognitive impairment and Alzheimer's disease
por: Mi, Yan, et al.
Publicado: (2023)

Editorial: Molecular mechanisms of Alzheimer’s disease: From top to bottom
por: Mello-Carpes, Pâmela B., et al.
Publicado: (2022)

Neuropathology of Aging in Cats and its Similarities to Human Alzheimer’s Disease
por: Sordo, Lorena, et al.
Publicado: (2021)

Friend or Foe? Defining the Role of Glutamate in Aging and Alzheimer’s Disease
por: Cox, MaKayla F., et al.
Publicado: (2022)

Amyloid-β in Alzheimer’s disease – front and centre after all?
por: Weglinski, Caroline, et al.
Publicado: (2023)

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer’s Disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2018)

Anosognosia in Amnestic Mild Cognitive Impairment Is Related to Diminished Hippocampal Volume Comparable to Alzheimer’s Disease Dementia: Preliminary MRI Findings
por: Flores-Vázquez, Juan Francisco, et al.
Publicado: (2021)

Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Xiang, Shuai, et al.
Publicado: (2022)

Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer’s disease pathology in mild cognitive impairment: a longitudinal cohort study
por: Wang, Hao, et al.
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer’s Disease
por: Kehmeier, Mackenzie N., et al.
Publicado: (2021)

Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review
por: Schreiner, Oliver Daniel, et al.
Publicado: (2023)

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease: A Proof-of-Concept Six Years Prospective Study
por: Ferreri, Florinda, et al.
Publicado: (2021)

Patterns of structure-function association in normal aging and in Alzheimer's disease: Screening for mild cognitive impairment and dementia with ML regression and classification models
por: Statsenko, Yauhen, et al.
Publicado: (2023)

A cross-sectional study of retinal vessel changes based on optical coherence tomography angiography in Alzheimer’s disease and mild cognitive impairment
por: Ma, Xiaoyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tue5g7fp4dp7da9jteaqtb6050